Answers are grounded in this paper and cite their sources.
Cuproptosis, a novel form of programmed cell death induced by intracellular copper overload, provokes mitochondrial tricarboxylic acid (TCA) cycle collapse and metabolic dysfunction. This process can be potentiated by reactive oxygen species (ROS)‐burst strategies, including chemodynamic therapy (CDT) and photothermal therapy (PTT). Given the pronounced reliance of aggressive prostate cancer (PCa) cells on TCA cycle energy metabolism, therapeutic approaches that sensitize malignancies to cuproptosis hold significant promise. This study develops a tumor‐targeted nanolock (HA@CuHPT‐IR780) by coordinating copper ions with a catechol ligand, incorporating the photosensitizer IR780, and functionalizing the surface with hyaluronic acid for enhanced tumor targeting. The nanolock remains stable in a “locked” state under normal physiological conditions but disassembles upon exposure to glutathione (GSH), concurrently depleting GSH while releasing 2,3,6,7,10,11‐hexahydroxytriphenylene (HPT), Cu + , and IR780. Liberated HPT elevates intracellular hydrogen peroxide (H 2 O 2 ) levels, and Cu + converts H 2 O 2 into cytotoxic hydroxyl radicals (•OH) via a Fenton‐like reaction. Near‐infrared (NIR) irradiation further amplifies ROS generation via a photothermal effect and disrupts mitochondrial metabolism to potentiate cuproptosis. In vitro and in vivo experiments confirm cuproptosis induction in PCa cells via synergistic chemodynamic‐photothermal therapy with minimal systemic toxicity. Collectively, this work proposes a promising multimodal therapeutic regimen for advanced PCa.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: